Pattern Computer Advances Promising Combination Therapy Candidates for Ovarian Cancer Through First Round of In Vitro Studies
REDMOND, WA, May 24, 2022 -- Pattern ComputerĀ®, Inc. (PCI) is pleased to announce the advancement of our potential combination therapy candidates against High-grade Serous Ovarian cancer beyond the first stage of in vitro studies. In both cases, the [...]